This inventor holds 1 USPTO granted patent. Top assignee: Ripple Therapeutics Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Judith Anne Williams: Innovator in Pharmaceutical Science
Introduction
Judith Anne Williams is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. Her work focuses on enhancing the efficacy and delivery of medications.
Latest Patents
Judith holds a patent for "Crystalline forms of dexamethasone dimers and uses thereof." This patent features polymorphs of a prodrug dimer of dexamethasone linked at the 21-C and 21'-C carbons via a carbonate-triethylene glycol-carbonate linker. The disclosure includes pharmaceutical compositions and articles comprising these polymorphs, as well as their use in treating various diseases or conditions through the extended or controlled release of dexamethasone.
Career Highlights
Judith is currently associated with Ripple Therapeutics Corporation, where she continues to advance her research and development efforts. Her innovative approach has led to the creation of new pharmaceutical solutions that aim to improve patient outcomes.
Collaborations
Judith has collaborated with notable colleagues, including Ian Charles Parrag and Matthew Alexander John Statham. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Judith Anne Williams exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and work at Ripple Therapeutics Corporation highlight her commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile